Key Insights

Highlights

Success Rate

75% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

10.5%

6 terminated out of 57 trials

Success Rate

75.0%

-11.5% vs benchmark

Late-Stage Pipeline

14%

8 trials in Phase 3/4

Results Transparency

17%

3 of 18 completed with results

Key Signals

3 with results75% success

Data Visualizations

Phase Distribution

48Total
Not Applicable (12)
P 1 (9)
P 2 (19)
P 3 (5)
P 4 (3)

Trial Status

Completed18
Unknown13
Recruiting7
Not Yet Recruiting6
Terminated6
Withdrawn4

Trial Success Rate

75.0%

Benchmark: 86.5%

Based on 18 completed trials

Clinical Trials (57)

Showing 20 of 20 trials
NCT07570914Phase 2Not Yet Recruiting

Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver Metastases

NCT06356584Phase 2Recruiting

Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Metastases

NCT07476651Not ApplicableRecruiting

Scout Dose of Resin Microspheres

NCT03785210Phase 2Terminated

Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers

NCT07314385Phase 1Not Yet Recruiting

NH002-mediated Sonoporation With Chemotherapy in Advanced Pancreatic Cancer

NCT07256223Phase 2Not Yet Recruiting

A Clinical Trial of Envafolimab Combined With Lenvatinib for Kidney Cancer With Liver Spread

NCT07180641Completed

National Registry of Hepatic Metastases From Non-Colorectal Cancer"

NCT07118566Phase 2Not Yet Recruiting

Hyperthermia Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Gastrointestinal Malignancies With Liver Metastases

NCT07001592Phase 1Recruiting

Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors

NCT06980792Completed

Surgical Approach for Adenocarcinoma of the Pancreas With Synchronous Liver Metastases

NCT06848465Phase 1Recruiting

LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver Metastasis

NCT03428477Phase 3Active Not RecruitingPrimary

EPA for Metastasis Trial 2

NCT05098847Phase 2RecruitingPrimary

Cryoablation Combined with Sintilimab Plus Lenvatinib in Previously Treated Unresectable Liver Metastasis from Solid Tumors

NCT06779708Completed

The Role of Intraoperative Hepatic Ultrasonography in Gastrointestinal or Pancreatic Neuroendocrine Tumor

NCT06671418Phase 3Enrolling By Invitation

Primary Percutaneous Stenting Above the Ampulla Versus Endoscopic Drainage for Unresectable Malignant Hilar Biliary Obstruction

NCT04622423Recruiting

Advanced Therapies for Liver Metastases

NCT06609434Not ApplicableNot Yet Recruiting

The Role and Safety of Radiofrequency Ablation in Recurrent Liver Metastasis of Colorectal Cancer

NCT02597348Not ApplicableActive Not RecruitingPrimary

Liver Transplantation in Patients With Unresectable Colorectal Liver Metastases Treated by Chemotherapy

NCT01479608Not ApplicableRecruiting

Liver Transplantation and Colorectal Cancer

NCT00430313Not ApplicableWithdrawn

Effects of Acupoint Electro-stimulation on Preventing Nausea and Vomiting Induced by Cisplatin or Oxaliplatin

Scroll to load more

Research Network

Activity Timeline